Plasma levels of CXCL12 are known to be elevated in HIV-infected individuals [57], and evidence suggests that CXCL12 can be converted to a highly neurotoxic protein after proteolytic processing by active matrix metalloproteinase-2 (MMP2), which is also elevated in response to HIV infection. The gene discussed is MMP2; the disease is HIV infectious disease.